(I'm not )
Select a date:
June 18, 2013
June 17, 2013
June 16, 2013
June 15, 2013
June 14, 2013
June 13, 2013
June 12, 2013
June 11, 2013
June 10, 2013
June 9, 2013
June 8, 2013
June 7, 2013
June 6, 2013
June 5, 2013
June 4, 2013
June 3, 2013
June 2, 2013
June 1, 2013
May 31, 2013
May 30, 2013
May 29, 2013
May 28, 2013
May 27, 2013
May 26, 2013
May 25, 2013
May 24, 2013
May 23, 2013
May 22, 2013
May 21, 2013
May 20, 2013
Click here to add topics
Click here to add companies
Top World News
Industry News, A-Z
Futures market survey: 80 pct bearish about Shanghai gold on Wed.
Look for Shares of Direxion Daily Gold Miners Bull 2x Shares to Potentially Rebound after Yesterday's 8.44% Sell Off
Plans, partnership re-imagine Waller Creek as natural oasis
Watch for Barrick Gold to Potentially Rebound After Falling 2.68% Yesterday
Tullow Wins Heritage Case
Ernst & Young Global Survey Reveals Critical Role Sports Play for Female Executives in Leadership Development and Teamwork in Business
Interview: Israeli president calls for closer bilateral cooperation with China
Backhoe caused gas leak, closure of High Point Road
SmarTrend Watching for Potential Rebound in Shares of Market Vectors - Gold Miners ETF After 2.87% Loss
Book is the cherry on top of Ferry Farm's long story
Top World News
Aerospace & Defense
Oil & Gas
Computer Apps, Software & OS
Computer Database & Data Storage
Research and Markets (http://www.researchandmarkets.com/research/jjnvm7/triple_analysis) has announced the addition of the "Triple Analysis: Melanoma, Prostate Cancer and Cancer Vaccines" report to their offering....
BusinessWire, 11:03am ET
Research and Markets (http://www.researchandmarkets.com/research/nr75bj/triple_analysis) has announced the addition of the "Triple Analysis: Leukemia, Prostate Cancer and Cancer Vaccines" report to their offering....
BusinessWire, 10:53am ET
Triple Analysis: Melanoma, Prostate Cancer and Cancer Vaccines
Research and Markets (http://www.researchandmarkets.com/research/73dxfl/triple_analysis) has announced the addition of the "Triple Analysis: Melanoma, Prostate Cancer and Cancer Vaccines" report to their offering. This triple analysis focuses on...
M2, 10:08am ET
Triple Analysis: Leukemia, Prostate Cancer and Cancer Vaccines
Research and Markets (http://www.researchandmarkets.com/research/blzf93/triple_analysis) has announced the addition of the "Triple Analysis: Leukemia, Prostate Cancer and Cancer Vaccines" report to their offering. This triple analysis focuses on...
M2, 9:58am ET
EDAP Granted European Market Clearance for Focal.One(R)
EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that it received CE Mark (European regulatory approval) for Focal.One, its new and innovative robotic HIFU device fully dedicated to focal therapy of prostate...
GlobeNewswire, 9:13am ET
RDInvesting Provides Investors with Free In-Depth Equity Reports on ALGN, MDVN, PNK and SPLS
Align Technology, Inc. (NASDAQ: ALGN) shares increased 2.43 percent to close at $35.87 a share Monday. The stock traded in between $35.49 and $36.17 on volume of 366,240 shares traded. Stifel Nicolaus currently have a "buy" rating on the company...
ACCESSWIRE, 8:48am ET
FDA Grants Prostate IDE Approval for AngioDynamics' NanoKnife System
AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced the U.S. Food & Drug Administration (FDA) has granted...
GlobeNewswire, 6:38am ET
Market Maker Surveillance Report. PXLW, EDAP, SGOC, ORMP, GNMK, CERE, Losing Stocks With Lowest Price Friction For Monday, June 17th 2013
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Monday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This...
M2, 5:13am ET
Johnson & Johnson to acquire Aragon Pharmaceuticals in a USD1,000m transaction
Global healthcare company Johnson & Johnson (NYSE:JNJ) announced on Monday the signing of a definitive agreement to acquire Aragon Pharmaceuticals Inc, a pharmaceutical discovery and development company focused on drugs to treat...
M2, 4:48am ET
WMIS Welcomes CMS Decision: Expanding Coverage for FDG-PET and Ending NOPR Data
On June 11, 2013 the Centers for Medicare & Medicaid Services (CMS) released a final decision memorandum concluding that FDG Position Emission Tomography (PET) is nationally covered to guide subsequent management of anti-tumor strategy, and...
PRWeb, 4:33am ET
Midbrook Medical Becomes an Educator on Infection Prevention and a Valuable Resource for Those in the Healthcare World
Hospital-acquired infections (HAIs) are the 4th leading cause of death in the United States. They kill more people every year than breast cancer, prostate cancer, and automobile accidents combined. One route of HAI transmission comes from reused...
PRWeb, 3:13am ET
MDxHealth Announces Changes to Its Board of Directors
MDxHealth SA (EURONEXT BRUSSELS: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer treatment, today announced changes to the composition of its Board of Directors, including the...
Marketwire, 3:03am ET
1-12 of 12
Terms of Service